Larvol Delta - March-Biosciences-Awarded-134-Million-by-CPRIT-to-Advance-Its-CD5-CART-Therapy-for-Tcell-Lymphoma-in-Phase-2-Trials

MB-105 - March Bio

https://www.prnewswire.com/news-releases/march-biosciences-awarded-13-4-million-by-cprit-to-advance-its-cd5-car-t-therapy-for-t-cell-lymphoma-in-phase-2-trials-301991941.html

Nov 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next